Browse by Journal Title

2024

Piezo2 voltage-block regulates mechanical pain sensitivity.
Sánchez-Carranza, O., Chakrabarti, S., Kühnemund, J., Schwaller, F., Bégay, V., García-Contreras, J.A., Wang, Lin and Lewin, G.R.
Brain 147 (10): 3487-3500. October 2024

2023

Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Cortese, R., Battaglini, M., Prados, F., Bianchi, A., Haider, L., Jacob, A., Palace, J., Messina, S., Paul, F., Wuerfel, J., Marignier, R., Durand-Dubief, F., de Medeiros Rimkus, C., Callegaro, D., Sato, D.K., Filippi, M., Rocca, M.A., Cacciaguerra, L., Rovira, A., Sastre-Garriga, J., Arrambide, G., Liu, Y., Duan, Y., Gasperini, C., Tortorella, C., Ruggieri, S., Amato, M.P., Ulivelli, M., Groppa, S., Grothe, M., Llufriu, S., Sepulveda, M., Lukas, C., Bellenberg, B., Schneider, R., Sowa, P., Celius, E.G., Proebstel, A.K., Yaldizli, Ö., Müller, J., Stankoff, B., Bodini, B., Carmisciano, L., Sormani, M.P., Barkhof, F., De Stefano, N. and Ciccarelli, O.
Brain 146 (6): 2489-2501. June 2023

Parallel in-depth analysis of repeat expansions in ataxia patients by long-read sequencing.
Erdmann, H., Schöberl, F., Giurgiu, M., Leal Silva, R.M., Scholz, V., Scharf, F., Wendlandt, M., Kleinle, S., Deschauer, M., Nübling, G., Heide, W., Babacan, S.S., Schneider, C., Neuhann, T., Hahn, K., Schoser, B., Holinski-Feder, E., Wolf, D.A. and Abicht, A.
Brain 146 (5): 1831-1843. May 2023

The genomic landscape across 474 surgically accessible epileptogenic human brain lesions.
López-Rivera, J.A., Leu, C., Macnee, M., Khoury, J., Hoffmann, L., Coras, R., Kobow, K., Bhattarai, N., Pérez-Palma, E., Hamer, H., Brandner, S., Rössler, K., Bien, C.G., Kalbhenn, T., Pieper, T., Hartlieb, T., Butler, E., Genovese, G., Becker, K., Altmüller, J., Niestroj, L.M., Ferguson, L., Busch, R.M., Nürnberg, P., Najm, I., Blümcke, I. and Lal, D.
Brain 146 (4): 1342-1356. April 2023

2022

Mutations in TAF8 cause a neurodegenerative disorder.
Wong, K.M., Jepsen, W.M., Efthymiou, S., Salpietro, V., Sanchez-Castillo, M., Yip, J., Kriouile, Y., Diegmann, S., Dreha-Kulaczewski, S., Altmüller, J., Thiele, H., Nürnberg, P., Toosi, M.B., Akhondian, J., Ghayoor Karimiani, E., Hummel-Abmeier, H., Huppke, B., Houlden, H., Gärtner, J., Maroofian, R. and Huppke, P.
Brain 145 (9): 3022-3034. September 2022

Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state.
Smajić, S., Prada-Medina, C.A., Landoulsi, Z., Ghelfi, J., Delcambre, S., Dietrich, C., Jarazo, J., Henck, J., Balachandran, S., Pachchek, S., Morris, C.M., Antony, P., Timmermann, B., Sauer, S., Pereira, S.L., Schwamborn, J.C., May, P., Grünewald, A. and Spielmann, M.
Brain 145 (3): 964-978. March 2022

2020

Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.
Petrou, P., Kassis, I., Levin, N., Paul, F., Backner, Y., Benoliel, T., Oertel, F.C., Scheel, M., Hallimi, M., Yaghmour, N., Hur, T.B., Ginzberg, A., Levy, Y., Abramsky, O. and Karussis, D.
Brain 143 (12): 3574-3588. December 2020

Aggressive multiple sclerosis - a matter of measurement and timing.
Ellenberger, D., Flachenecker, P., Fneish, F., Frahm, N., Hellwig, K., Paul, F., Stahmann, A., Warnke, C., Rommer, P.S. and Zettl, U.K.
Brain 143 (11): e97. November 2020

Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.
Dietrich, M., Koska, V., Hecker, C., Göttle, P., Hilla, A.M., Heskamp, A., Lepka, K., Issberner, A., Hallenberger, A., Baksmeier, C., Steckel, J., Balk, L., Knier, B., Korn, T., Havla, J., Martínez-Lapiscina, E.H., Solà-Valls, N., Manogaran, P., Olbert, E.D., Schippling, S., Cruz-Herranz, A., Yiu, H., Button, J., Caldito, N.G., von Gall, C., Mausberg, A.K., Stettner, M., Zimmermann, H.G., Paul, F., Brandt, A.U., Küry, P., Goebels, N., Aktas, O., Berndt, C., Saidha, S., Green, A.J., Calabresi, P.A., Fischer, D., Hartung, H.P. and Albrecht, P.
Brain 143 (4): 1127-1142. April 2020

2019

Decreased microglial Wnt/β-catenin signalling drives microglial pro-inflammatory activation in the developing brain.
Van Steenwinckel, J., Schang, A.L., Krishnan, M.L., Degos, V., Delahaye-Duriez, A., Bokobza, C., Csaba, Z., Verdonk, F., Montané, A., Sigaut, S., Hennebert, O., Lebon, S., Schwendimann, L., Le Charpentier, T., Hassan-Abdi, R., Ball, G., Aljabar, P., Saxena, A., Holloway, R.K., Birchmeier, W., Baud, O., Rowitch, D., Miron, V., Chretien, F., Leconte, C., Besson, V.C., Petretto, E.G., Edwards, A.D., Hagberg, H., Soussi-Yanicostas, N., Fleiss, B. and Gressens, P.
Brain 142 (12): 3806-3833. December 2019

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.
Filippi, M., Preziosa, P., Banwell, B.L., Barkhof, F., Ciccarelli, O., De Stefano, N., Geurts, J.J.G., Paul, F., Reich, D.S., Toosy, A.T., Traboulsee, A., Wattjes, M.P., Yousry, T.A., Gass, A., Lubetzki, C., Weinshenker, B.G. and Rocca, M.A.
Brain 142 (7): 1858-1875. July 2019

2017

Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.
Niturad, C.E., Lev, D., Kalscheuer, V.M., Charzewska, A., Schubert, J., Lerman-Sagie, T., Kroes, H.Y., Oegema, R., Traverso, M., Specchio, N., Lassota, M., Chelly, J., Bennett-Back, O., Carmi, N., Koffler-Brill, T., Iacomino, M., Trivisano, M., Capovilla, G., Striano, P., Nawara, M., Rzonca, S., Fischer, U., Bienek, M., Jensen, C., Hu, H., Thiele, H., Altmüller, J., Krause, R., May, P., Becker, F., Balling, R., Biskup, S., Haas, S.A., Nürnberg, P., van Gassen, K.L.I., Lerche, H., Zara, F., Maljevic, S. and Leshinsky-Silver, E.
Brain 140 (11): 2879-2894. 1 November 2017

2016

Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis.
Kreye, J., Wenke, N.K., Chayka, M., Leubner, J., Murugan, R., Maier, N., Jurek, B., Ly, L.T., Brandl, D., Rost, B.R., Stumpf, A., Schulz, P., Radbruch, H., Hauser, A.E., Pache, F., Meisel, A., Harms, L., Paul, F., Dirnagl, U., Garner, C., Schmitz, D., Wardemann, H. and Prüss, H.
Brain 139 (10): 2641-2652. 1 October 2016

Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury.
Bartus, K., Galino, J., James, N.D., Hernandez-Miranda, L.R., Dawes, J.M., Fricker, F.R., Garratt, A.N., McMahon, S.B., Ramer, M.S., Birchmeier, C., Bennett, D.L.H. and Bradbury, E.J.
Brain 139 (Pt 5): 1394-1416. May 2016

2015

CHD2 variants are a risk factor for photosensitivity in epilepsy.
Galizia, E.C., Myers, C.T., Leu, C., de Kovel, C.G.F., Afrikanova, T., Cordero-Maldonado, M.L., Martins, T.G., Jacmin, M., Drury, S., Krishna Chinthapalli, V., Muhle, H., Pendziwiat, M., Sander, T., Ruppert, A.K., Møller, R.S., Thiele, H., Krause, R., Schubert, J., Lehesjoki, A.E., Nürnberg, P., Lerche, H., Palotie, A., Coppola, A., Striano, S., Gaudio, L.D., Boustred, C., Schneider, A.L., Lench, N., Jocic-Jakubi, B., Covanis, A., Capovilla, G., Veggiotti, P., Piccioli, M., Parisi, P., Cantonetti, L., Sadleir, L.G., Mullen, S.A., Berkovic, S.F, Stephani, U., Helbig, I., Crawford, A.D., Esguerra, C.V., Kasteleijn-Nolst Trenité, D.G.A., Koeleman, B.P.C., Mefford, H.C., Scheffer, I.E. and Sisodiya, S.M.
Brain 138 (5): 1198-1207. May 2015

Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
Vos, S.J.B., Verhey, F., Froelich, L., Kornhuber, J., Wiltfang, J., Maier, W., Peters, O., Ruether, E., Nobili, F., Morbelli, S., Frisoni, G.B., Drzezga, A., Didic, M., van Berckel, B.N.M., Simmons, A., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., Muscio, C., Herukka, S.K., Salmon, E., Bastin, C., Wallin, A., Nordlund, A., de Mendonca, A., Silva, D., Santana, I., Lemos, R., Engelborghs, S., Van der Mussele, S., Freund-Levi, Y., Wallin, A.K., Hampel, H., van der Flier, W., Scheltens, P. and Visser, P.J.
Brain 138 (Pt 5): 1327-1338. May 2015

New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis.
Hoppmann, N., Graetz, C., Paterka, M., Poisa-Beiro, L., Larochelle, C., Hasan, M., Lill, C.M., Zipp, F. and Siffrin, V.
Brain 138 (Pt 4): 902-917. April 2015

2013

Axonal neuregulin 1 is a rate limiting but not essential factor for nerve remyelination.
Fricker, F.R., Antunes-Martins, A., Galino, J., Paramsothy, R., La Russa, F., Perkins, J., Goldberg, R., Brelstaff, J., Zhu, N., McMahon, S.B., Orengo, C., Garratt, A.N., Birchmeier, C. and Bennett, D.L.
Brain 136 (Pt 7): 2279-2297. July 2013

Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Jolivel, V., Luessi, F., Masri, J., Kraus, S.H.P., Hubo, M., Poisa-Beiro, L., Klebow, S., Paterka, M., Yogev, N., Tumani, H., Furlan, R., Siffrin, V., Jonuleit, H., Zipp, F. and Waisman, A.
Brain 136 (4): 1048-1066. 1 April 2013

2012

Essential role of interleukin-6 in post-stroke angiogenesis.
Gertz, K., Kronenberg, G., Kaelin, R.E., Baldinger, T., Werner, C., Balkaya, M., Eom, G.D., Hellmann-Regen, J., Kroeber, J., Miller, K.R., Lindauer, U., Laufs, U., Dirnagl, U., Heppner, F.L. and Endres, M.
Brain 135 (Pt 6): 1964-1980. June 2012

2011

Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.
Brandt, A.U., Oberwahrenbrock, T., Ringelstein, M., Young, K.L., Tiede, M., Hartung, H.P., Martin, R., Aktas, O., Paul, F. and Schippling, S.
Brain 134 (Pt 11): e193. November 2011

2010

Irregular RNA splicing curtails postsynaptic gephyrin in the cornu ammonis of patients with epilepsy.
Foerstera, B., Belaidi, A.A., Juettner, R., Bernert, C., Tsokos, M., Lehmann, T.N., Horn, P., Dehnicke, C., Schwarz, G. and Meier, J.C.
Brain 133 (Pt12): 3778-3794. December 2010

Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells.
Chirasani, S.R., Sternjak, A., Wend, P., Momma, S., Campos, B., Herrmann, I.M., Graf, D., Mitsiadis, T., Herold-Mende, C., Besser, D., Synowitz, M., Kettenmann, H. and Glass, R.
Brain 133 (Pt 7): 1961-1972. July 2010

2009

ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte, S., von Ahsen, N., Kruse, N., Huber, B., Winkelmann, A., Zettl, U.K., Starck, M., Koenig, N., Tellez, N., Doerr, J., Paul, F., Zipp, F., Luehder, F., Koepsell, H., Pannek, H., Montalban, X., Gold, R. and Chan, A.
Brain 132 (Pt 9): 2517-2530. September 2009

Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization.
Siffrin, V., Brandt, A.U., Radbruch, H., Herz, J., Boldakowa, N., Leuenberger, T., Werr, J., Hahner, A., Schulze-Topphoff, U., Nitsch, R. and Zipp, F.
Brain 132 (5): 1247-1258. May 2009

2008

Perivascular spaces - MRI marker of inflammatory activity in the brain?
Wuerfel, J., Haertle, M., Waiczies, H., Tysiak, E., Bechmann, I., Wernecke, K.D., Zipp, F. and Paul, F.
Brain 131 (Pt 9): 2332-2340. September 2008

Epilepsy and mental retardation limited to females: an under-recognized disorder.
Scheffer, I.E., Turner, S.J., Dibbens, L.M., Bayly, M.A., Friend, K., Hodgson, B., Burrows, L., Shaw, M., Chen, W., Ullmann, R., Ropers, H.H., Szepetowski, P., Haan, E., Mazarib, A., Afawi, Z., Neufeld, M.Y., Andrews, P.I., Wallace, G., Kivity, S., Lev, D., Lerman-Sagie, T., Derry, C.P., Korczyn, A.D., Gecz, J., Mulley, J.C. and Berkovic, S.F.
Brain 131 (4): 918-927. April 2008

2007

Pathological consequences of VCP mutations on human striated muscle.
Huebbers, C.U., Clemen, C.S., Kesper, K., Boeddrich, A., Hofmann, A., Kaemaeraeinen, O., Tolksdorf, K., Stumpf, M., Reichelt, J., Roth, U., Krause, S., Watts, G., Kimonis, V., Wattjes, M.P., Reimann, J., Thal, D.R., Biermann, K., Evert, B.O., Lochmueller, H., Wanker, E.E., Schoser, B.G., Noegel, A.A. and Schroeder, R.
Brain 130 (2): 381-393. 1 February 2007

The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A.
Sliwa, M., Markovic, D., Gabrusiewicz, K., Synowitz, M., Glass, R., Zawadzka, M., Wesolowska, A., Kettenmann, H. and Kaminska, B.
Brain 130 (Pt. 2): 476-489. 1 February 2007

2003

A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core-like lesions.
Gommans, I.M.P., Davis, M., Saar, K., Lammens, M., Mastaglia, F., Lamont, P., Van Duijnhoven, G., Ter Laak, H.J., Reis, A., Vogels, O.J.M., Laing, N., van Engelen, B.G.M. and Kremer, H.
Brain 126 (7): 1545-1551. July 2003

1996

Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery.
Filippi, M., Yousry, T., Baratti, C., Horsfield, M.A., Mammi, S., Becker, C., Voltz, R., Spuler, S., Campi, A., Reiser, M.F. and Comi, G.
Brain 119 (4): 1349-1355. August 1996